Dana Hilt
Vermogen: 974 000 $ op 30-09-2026
Vermogen: 974 000 $ op 30-09-2026
Dr. Dana C.
Hilt, MD, is a Chief Medical Officer at Actinogen Medical Ltd. Dr. Hilt was previously employed as a Chief Medical Officer by Frequency Therapeutics, Inc., a Chief Medical Officer by Lysosomal Therapeutics, Inc., a Chief Medical Officer by Critical Therapeutics, Inc., a Chief Medical Officer & SVP-Drug Development by FORUM Pharmaceuticals, Inc., a Director-Clinical Neurosciences by Amgen, Inc., a Chief Medical Officer by Ascend Pharmaceuticals, Inc., a Chief Medical Officer & SVP-Clinical Research by ASCEND Therapeutics US LLC, a Chief Medical Officer by Brenig Therapeutics, Inc., and a Vice President-Clinical Research by Guilford Pharmaceuticals, Inc. He received his undergraduate degree from the University of Maine and a doctorate degree from Tufts University School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-08-2025 | 25.000.000 ( 0,65% ) | 974 000 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-02-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Hoofd Techniek/Wetenschap/O&O | 10-06-2025 |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Hoofd Techniek/Wetenschap/O&O | 01-08-2019 |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Hoofd Techniek/Wetenschap/O&O | 25-09-2007 |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Hoofd Techniek/Wetenschap/O&O | - |
| KORRO BIO, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
University of Maine
University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinogen Medical Ltd.
Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
Ascend Pharmaceuticals, Inc. | |
ASCEND Therapeutics US LLC
ASCEND Therapeutics US LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company develops hormone therapies | Health Technology |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecules for use in the treatment of neurodegenerative diseases | Health Technology |
Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Brenig Therapeutics, Inc.
Brenig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of neurology targets | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau